Levetiracetam administration is correlated with lower mortality in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes
Chinese Medical Journal2019Vol. 132(3), pp. 269–274
Citations Over Time
Abstract
The LEV administration is associated with lower mortality in patients with MELAS in this retrospective study. Further laboratory research and prospective cohort studies are needed to confirm whether LEV has neuroprotective effects on patients with mitochondrial diseases.
Related Papers
- → The teratogenicity of the newer antiepileptic drugs - an update(2014)78 cited
- → Initial anticonvulsant monotherapy in routine care of children and adolescents: levetiracetam fails more frequently than valproate and oxcarbazepine due to a lack of effectiveness(2013)24 cited
- → Levetiracetam and topiramate poisoning: Two overdoses on those drugs with no lasting effects(2017)6 cited
- Comparative analysis of levetiracetam and oxcarbazepine in treating of children with epilepsy(2014)
- Efficacy Compared of Levetiracetam and Topiramate Monotherapy on Children with Epilepsy(2010)